P>Background Although the total to high-density lipoprotein cholesterol ratio (TC/HDL-C) has been used for decades to identify individuals at risk for coronary heart disease (CHD), apolipoprotein-based (apolipoprotein B/apolipoprotein A-I [apoB/apoA-I]) and nuclear magnetic resonance spectroscopy (NMR)-based lipoprotein concentrations (low-density lipoprotein(NMR)/high-density lipoprotein(NMR) [LDLNMR/HDLNMR]) may also be useful for CHD risk stratification. Materials and methods In a case-control study conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study population, 870 individuals who developed CHD during a 6-year follow-up were matched to 1659 controls on the basis of gender, age and enrol...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
The blood level of lipids, apolipoproteins, and lipid ratios are important predictors of some chroni...
Aim/hypothesis. To examine whether nuclear magnetic resonance lipoprotein spectroscopy improves the ...
Background and aim Atherosclerosis is the underlying process in cardiovascular disease (CVD), the...
The role of low density lipoprotein (LDL) cholesterol as a major risk factor for the development of ...
BACKGROUND: The contribution of apolipoprotein A-I (apoA-I) to coronary heart disease (CHD) risk str...
Aims: Apolipoprotein C-III (apoC-III) has been recognized as a useful marker of triglyceride-rich li...
Background: The sex differential in coronary heart disease (CHD) risk, which is not explained by mal...
Background: The contribution of apolipoprotein A‐I (apoA‐I) to coronary heart disease (CHD) risk str...
Funder: Sigrid Juselius Foundation, FinlandFunder: NIHR Cambridge Biomedical Research Centre (GB)Bac...
Objective. We assess predictive abilities among subjects with metabolic syndrome (MetS) of CVD risk ...
Background: Blood lipids, particularly the cholesterol in low-density lipoproteins (LDL-C), are caus...
AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C...
Background\ud \ud The relationship between cigarette smoking and cardiovascular disease is well esta...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
The blood level of lipids, apolipoproteins, and lipid ratios are important predictors of some chroni...
Aim/hypothesis. To examine whether nuclear magnetic resonance lipoprotein spectroscopy improves the ...
Background and aim Atherosclerosis is the underlying process in cardiovascular disease (CVD), the...
The role of low density lipoprotein (LDL) cholesterol as a major risk factor for the development of ...
BACKGROUND: The contribution of apolipoprotein A-I (apoA-I) to coronary heart disease (CHD) risk str...
Aims: Apolipoprotein C-III (apoC-III) has been recognized as a useful marker of triglyceride-rich li...
Background: The sex differential in coronary heart disease (CHD) risk, which is not explained by mal...
Background: The contribution of apolipoprotein A‐I (apoA‐I) to coronary heart disease (CHD) risk str...
Funder: Sigrid Juselius Foundation, FinlandFunder: NIHR Cambridge Biomedical Research Centre (GB)Bac...
Objective. We assess predictive abilities among subjects with metabolic syndrome (MetS) of CVD risk ...
Background: Blood lipids, particularly the cholesterol in low-density lipoproteins (LDL-C), are caus...
AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C...
Background\ud \ud The relationship between cigarette smoking and cardiovascular disease is well esta...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) a...
The blood level of lipids, apolipoproteins, and lipid ratios are important predictors of some chroni...
Aim/hypothesis. To examine whether nuclear magnetic resonance lipoprotein spectroscopy improves the ...